PELL Bio-Med Technology Co (TPE:6949) FCF Margin % : -4,708.06% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is PELL Bio-Med Technology Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PELL Bio-Med Technology Co's Free Cash Flow for the three months ended in Dec. 2024 was NT$-218.36 Mil. PELL Bio-Med Technology Co's Revenue for the three months ended in Dec. 2024 was NT$4.64 Mil. Therefore, PELL Bio-Med Technology Co's FCF Margin % for the quarter that ended in Dec. 2024 was -4,708.06%.

As of today, PELL Bio-Med Technology Co's current FCF Yield % is -7.78%.

The historical rank and industry rank for PELL Bio-Med Technology Co's FCF Margin % or its related term are showing as below:

TPE:6949' s FCF Margin % Range Over the Past 10 Years
Min: -2669.76 Med: -1038.67 Max: -875.12
Current: -2669.76

During the past 4 years, the highest FCF Margin % of PELL Bio-Med Technology Co was -875.12%. The lowest was -2669.76%. And the median was -1038.67%.

TPE:6949's FCF Margin % is ranked worse than
85.6% of 1007 companies
in the Biotechnology industry
Industry Median: -127.22 vs TPE:6949: -2669.76

PELL Bio-Med Technology Co FCF Margin % Historical Data

The historical data trend for PELL Bio-Med Technology Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PELL Bio-Med Technology Co FCF Margin % Chart

PELL Bio-Med Technology Co Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

FCF Margin %

-875.12

-987.80

-1,089.53

-2,669.76

PELL Bio-Med Technology Co Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial						-1,779.91	-1,127.53	-796.59	-4,205.50	-4,708.06

Competitive Comparison of PELL Bio-Med Technology Co's FCF Margin %

For the Biotechnology subindustry, PELL Bio-Med Technology Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PELL Bio-Med Technology Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PELL Bio-Med Technology Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PELL Bio-Med Technology Co's FCF Margin % falls into.

Save Embed

;

Save Embed

;

PELL Bio-Med Technology Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PELL Bio-Med Technology Co's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-524.1	/	19.631
	=	-2,669.76 %

PELL Bio-Med Technology Co's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-218.36	/	4.638
	=	-4,708.06 %

PELL Bio-Med Technology Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of PELL Bio-Med Technology Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

PELL Bio-Med Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PELL Bio-Med Technology Co Ltd (TPE:6949) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN

Website

https://www.pellbmt.com

PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell).

PELL Bio-Med Technology Co Headlines

No Headlines